LW vs MNPR · P/E 21, rev $6.61B vs $431.4M cap
Lamb Weston Holdings Inc (LW) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
Lamb Weston Holdings Inc (LW) is a packaged foods company listed on US.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported LW revenue for 2026-05-31 was $6.61B. Net income was $290.0M. Revenue was up 2.5% from 2025-05-25 to 2026-05-31. LW currently screens at market cap $7.40B and trailing P/E 20.6.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
LW currently screens at market cap $7.40B and trailing P/E 20.6. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the LW and MNPR stock pages for the full models.
Not investment advice.